Iconic Therapeutics Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 15

Iconic Therapeutics General Information

Description

Developer of immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases. The company's proteins work with the body's immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of leading causes of blindness, enabling physicians to develop a new approach to retinal disease and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 701 Gateway Boulevard
  • Suite 100
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Iconic Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Iconic Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 22-Aug-2019 00000 Completed Generating Revenue
8. Debt - General 28-Jun-2019 0000 00000 Completed Generating Revenue
7. Later Stage VC (Series B) 15-Apr-2019 0000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series C1) 09-Aug-2016 000.00 000.00 00000 Completed Generating Revenue
5. Accelerator/Incubator 10-Jul-2015 000.00 Completed Generating Revenue
4. Later Stage VC (Series B1) 16-Apr-2014 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 14-Jan-2009 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 30-Apr-2007 $3.94M $8.62M 000.00 Completed Startup
1. Early Stage VC (Series A) 29-Dec-2004 $4.68M $4.68M 000.00 Completed Startup
To view Iconic Therapeutics’s complete valuation and funding history, request access »

Iconic Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B Prime 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series A Prime 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Iconic Therapeutics’s complete cap table history, request access »

Iconic Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious d
Drug Discovery
South San Francisco, CA
10 As of 2021
00000
0000000000 0 00000

00000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000 000000000
Cambridge, MA
00000
0000 0000-00-00
00000000000 00000

0000 000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iconic Therapeutics Competitors (67)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AavantiBio Venture Capital-Backed Cambridge, MA 00000 00000000000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
0000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 67 competitors. Get the full list »

Iconic Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
William Greene MD Chief Executive Officer & Board Member
Kirk Dornbush JD Co-Founder, Senior Advisor & Board Member
Gabriela Burian MD Chief Medical Officer
You’re viewing 3 of 5 executive team members. Get the full list »

Iconic Therapeutics Board Members (12)

Name Representing Role Since
Bruce Cohen Ph.D Self Board Member 000 0000
Bruce Robertson Ph.D H.I.G. BioHealth Partners Board Member 000 0000
Dirk Sauer Ph.D Iconic Therapeutics Board Member 000 0000
Julia Gregory Self Board Member 000 0000
Kirk Dornbush JD Iconic Therapeutics Co-Founder, Senior Advisor & Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Iconic Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Iconic Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novartis Corporation Minority 000 0000 000000 0
Cormorant Asset Management Hedge Fund Minority 000 0000 000000 0
Georgia Venture Partners Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
Osage University Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »